Coronavirus Update: Lilly’s Antibody Plus Remdesivir Trial Abandoned

Other Lilly and NIH Studies Continue

 
• By Scrip Team

Combination of antibody therapy and Gilead's Veklury fails to show potential in patients with advanced disease.  

Waiting In Line
Queens, New York: voters observe social distancing rules as they stand in line to take part in early voting for the US election on 3 November.

More from Business

More from Scrip